Department of Internal Medicine, Hedi Chaker Hospital, Sfax, Tunisia.
Med Princ Pract. 2017;26(5):427-432. doi: 10.1159/000481782. Epub 2017 Sep 26.
The aim of this work was to establish human leukocyte antigen (HLA) class I and hereditary hemochromatosis gene (HFE) mutation associations with recurrent aphthous oral ulcers (RAOU) and Behçet disease (BD) in a cohort of Southern Tunisian patients.
A total of 232 patients with RAOU and 123 healthy controls (HCs) were enrolled in this study. The patients were divided into 2 groups based on the presence (BD+: n = 62) or absence of BD (BD-, n = 170). In the BD+ group, 28 patients had severe manifestations of BD. In the BD- group, RAOU was isolated in 81 patients, associated with mucocutaneous manifestations in 58 and with joint symptoms in 25. Complement-dependent microlymphocytotoxicity assay and polymerase chain reaction-restriction fragment length polymorphism were used to study HLA class I polymorphism and HFE mutations, respectively.
HLA-B51 was positively associated with BD, particularly in those with severe manifestations. No association was detected with HLA class I polymorphism among the BD group. Based on stratification to clinical manifestations, the isolated RAOU was negatively associated with HLA-A1 with a difference close to significance (12 [14.81%] vs. 32 [26.02%] in HCs; p = 0.06). Furthermore, patients with mucocutaneous features had a higher frequency of HLA-B51 (14, 24.14%) than patients without mucocutaneous involvement (11, 11.37%). Considering HFE mutations, patients with isolated RAOU had a higher frequency of H63D when compared with other subgroups, especially after limiting the comparison to 27 patients of at least 5 years of follow-up.
This study showed that, unlike BD, RAOU were not associated with HLA-B51. Moreover, we suggest that H63D mutation was positively associated with isolated RAOU.
本研究旨在建立人类白细胞抗原(HLA)I 类和遗传性血色素沉着症基因(HFE)突变与复发性阿弗他口腔溃疡(RAOU)和贝切特病(BD)在南突尼斯患者队列中的关联。
共纳入 232 例 RAOU 患者和 123 例健康对照者(HCs)。根据是否存在 BD(BD+:n=62)或不存在 BD(BD-:n=170),将患者分为两组。BD+组中 28 例患者有 BD 的严重表现。BD-组中,81 例 RAOU 患者为孤立性,58 例伴有黏膜皮肤表现,25 例伴有关节症状。采用补体依赖性微量淋巴细胞毒性试验和聚合酶链反应-限制性片段长度多态性分析,分别研究 HLA I 类多态性和 HFE 突变。
HLA-B51 与 BD 呈正相关,尤其是在有严重表现的患者中。BD 组未发现与 HLA I 类多态性相关。根据临床表现分层,孤立性 RAOU 与 HLA-A1 呈负相关(12[14.81%]例 vs. HCs 中的 32[26.02%]例;p=0.06)。此外,黏膜皮肤特征患者 HLA-B51 频率较高(14 例,24.14%),而无黏膜皮肤受累患者频率较低(11 例,11.37%)。考虑到 HFE 突变,与其他亚组相比,孤立性 RAOU 患者 H63D 突变频率更高,尤其是在比较至少 5 年随访的 27 例患者时。
本研究表明,与 BD 不同,RAOU 与 HLA-B51 无关。此外,我们提示 H63D 突变与孤立性 RAOU 呈正相关。